Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients

Non-invasive assessment of NAFLD as systemic disease—A machine learning perspective

(2019) Ali Canbay et al.   PLoS One

Current treatment options for nonalcoholic fatty liver disease

(2019) Akshay Shetty et al.   CURRENT OPINION IN GASTROENTEROLOGY

Pharmacologic Inhibition of Epidermal Growth Factor Receptor Suppresses Non‐alcoholic Fatty Liver Disease in Murine Fast‐food Diet Model

(2019) Bharat Bhushan et al.   HEPATOLOGY

From NASH to HCC: current concepts and future challenges

(2019) Quentin M. Anstee et al.   Nature Reviews Gastroenterology & Hepatology

Repurposing drugs to target nonalcoholic steatohepatitis

(2019) Silvia Sookoian et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Noninvasive monitoring of hepatic steatosis: controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease

(2019) Sol Jae Lee et al.   Expert Review of Gastroenterology & Hepatology

Therapeutic effects of curcumin and ursodexycholic acid on non-alcoholic fatty liver disease

(2019) Shahsanam Gheibi et al.   BIOMEDICINE & PHARMACOTHERAPY

Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: in vitro and clinical study

(2018) M. Dallio et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Nonalcoholic Fatty Liver Disease and Metabolic Syndrome

(2018) Donghee Kim et al.   Clinics in Liver Disease

Insulin-Like Growth Factor (IGF) System in Liver Diseases

(2018) Agnieszka Adamek et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease

(2018) Mario Masarone et al.   Oxidative Medicine and Cellular Longevity

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

(2017) Leon A Adams et al.   GUT

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

(2017) Parambir S. Dulai et al.   HEPATOLOGY

Current and future pharmacological therapies for NAFLD/NASH

(2017) Yoshio Sumida et al.   JOURNAL OF GASTROENTEROLOGY

CD44 is a key player in non-alcoholic steatohepatitis

(2017) Stéphanie Patouraux et al.   JOURNAL OF HEPATOLOGY

Treatment of NAFLD with diet, physical activity and exercise

(2017) Manuel Romero-Gómez et al.   JOURNAL OF HEPATOLOGY

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years

(2017) Alessandro Federico et al.   MOLECULES

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease

(2017) Flavia A Cimini et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Treatment options for alcoholic and non-alcoholic fatty liver disease: A review

(2017) Sukhpreet Singh et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases

(2017) Nima Motamed et al.   Clinics and Research in Hepatology and Gastroenterology

Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments

(2017) Hironori Kitade et al.   Nutrients

Serum hepatocyte apoptosis biomarker predicts the presence of significant histological lesion in chronic hepatitis B virus infection

(2016) Zhu-Jun Cao et al.   DIGESTIVE AND LIVER DISEASE

EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease

(2016)   Obesity Facts

Interleukin-18–deficient mice develop dyslipidemia resulting in nonalcoholic fatty liver disease and steatohepatitis

(2016) Kyosuke Yamanishi et al.   Translational Research

The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment

(2015) Cristina Margini et al.   LIVER INTERNATIONAL

Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?

(2015) Mohamed Asrih et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently

(2014) Anja Beilfuss et al.   GUT

Serum Oxidative Stress Markers and Lipidomic Profile to Detect NASH Patients Responsive to an Antioxidant Treatment: A Pilot Study

(2014) Paola Stiuso et al.   Oxidative Medicine and Cellular Longevity

Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial

(2012) Carmela Loguercio et al.   FREE RADICAL BIOLOGY AND MEDICINE

Determination of reliability criteria for liver stiffness evaluation by transient elastography

(2012) Jérôme Boursier et al.   HEPATOLOGY

Metabolic effects of silibinin in the rat liver

(2011) Carina Parisoto Colturato et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Silybin and the liver: From basic research to clinical practice

(2011) Carmela Loguercio   WORLD JOURNAL OF GASTROENTEROLOGY

The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®

(2011) M. Sasso et al.   Clinics and Research in Hepatology and Gastroenterology

Diagnosis and Quantitation of Fibrosis

(2008) Diarmuid S. Manning et al.   GASTROENTEROLOGY